Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.
Sep 20, 2018
AHA responds to the Department of Health and Human Services Request for Information regarding the facilitation of a public-private dialogue to increase innovation and investment in the health care sector.
Sep 10, 2018
The AHA voiced support for a Federal Communications Commission proposal to create a $100 million pilot program to support telehealth for low-income Americans, calling the Connected Care Pilot Program “a critical next step towards delivering affordable telehealth services to those Americans who need it the most.”
Sep 7, 2018
Download the comment letter (PDF)
Sep 4, 2018
AHA comments on the Centers for Medicare & Medicaid Services’ calendar year 2019 proposed rule for the Home Health prospective payment system.
Aug 29, 2018
AHA comments on the Drug Enforcement Administration’s (DEA) notice of proposed rulemaking on aggregate production quotas for Schedule I and II controlled substances.
Aug 23, 2018
AHA letter to the US Senate supporting Amendment #3787 to address ‘out-of-control cost’ of prescription drugs.
Aug 3, 2018
RE: CMS-1720-NC, Request for Information Regarding the Physician Self-referral Law
Jul 30, 2018
AHA shares Value-Based Care recommendations with Congressional Caucus.
AHA Comments on CMS' Agency Information Collection Notice on the Home Health “Review Choice” DemonstrationJul 27, 2018
AHA comments on the Centers for Medicare & Medicaid Services' agency information collection notice on the home health “Review Choice” demonstration.
Jul 20, 2018
AHA letter to the Senate expressing support for Robert Wilkie Department.of Veteran Affairs Nomination.